<乌鸦传媒>Bad News on Anti-HER2 Heart Effects Exercise, however, may help improve cardio fitness in breast cancer survivors Jan 15, 2020
<乌鸦传媒>Oral Paclitaxel Bests IV Delivery in Advanced Breast Cancer But high pill count, lengthy dosing schedule could prove to be problematic Dec 14, 2019
<乌鸦传媒>Residual Breast Cancer Tool Highly Prognostic After Neoadjuvant Tx Tumor burden calculator predicted long-term outcomes in all breast cancer subtypes Dec 14, 2019
<乌鸦传媒>Anti-CDK4/6 Fails to Top Chemo in HR-Positive MBC Similar PFS with chemo, palbociclib plus exemestane or fulvestrant after progression on aromatase inhibitor Dec 13, 2019
<乌鸦传媒>HRT Has 20-Year Impact on Breast Cancer Risks Prospective data confirm long-term benefit with estrogen-only and harm with added progestin Dec 13, 2019
<乌鸦传媒>Checkpoints Show Different Outcomes in Breast Cancer Atezolizumab misses complete response benefit in triple negative patients Dec 13, 2019
<乌鸦传媒>T-DM1 Falls Short as Less-Toxic Option for Early Breast Cancer Promising efficacy but higher discontinuation rates and cost likely a deterrent Dec 13, 2019
<乌鸦传媒>Edging Closer to OS Benefit With Novel Anti-HER2 Drug Larger benefit with margetuximab in most common HER2 breast cancer phenotype Dec 12, 2019
<乌鸦传媒>New Standard for Metastatic HER2 Breast Cancer Consistent PFS, OS benefit with combination including oral HER2 inhibitor tucatinib Dec 11, 2019
<乌鸦传媒>Study Suggests Viable Alternative to Mastectomy After In-Breast Recurrence Mastectomy rates low, good cancer control in selected patients Nov 21, 2019
<乌鸦传媒>Sex Assault at Mt. Sinai; Pharma's MD Millionaires; Mammography Marketing Machine This past week in healthcare investigations Oct 23, 2019
<乌鸦传媒>Novel CDK 4/6 Inhibitor Fails in Triple Negative Breast Cancer Misses primary endpoints but has unexpected key benefit Oct 01, 2019
<乌鸦传媒>Neoadjuvant Anti-PD-1 Boosts pCR in TNBC Favorable trend toward improved event-free survival in preliminary analysis Sep 30, 2019
<乌鸦传媒>CDK 4/6 Inhibitors Boost OS in Advanced Breast Cancer Abemaciclib, ribociclib should become first-line treatment in HR-positive/HER2-negative disease, expert says Sep 29, 2019
<乌鸦传媒>Abemaciclib Offers Hope in HR+/HER2+Breast Cancer Phase II monarcHER trial shows better PFS with abemaciclib-trastuzumab-fulvestrant Sep 29, 2019
<乌鸦传媒>Wires or RFID Tags in Breast Cancer Excision? Women like the less obtrusive method, but small study doesn't quite settle question of whether there's a tradeoff Sep 24, 2019
<乌鸦传媒>The Legacy of Henry Lynch, MD Earlier this summer the legendary researcher passed, his contributions to cancer research are immeasurable Sep 01, 2019
<乌鸦传媒>Olivia Newton-John's Stage 4 Cancer Cannabis Management The singer and actress updates fans on her battle, but can marijuana help? Aug 22, 2019
<乌鸦传媒>Total Chemo Dose Still Matters in Breast Cancer Worse survival with cumulative dose Aug 20, 2019
<乌鸦传媒>MRI Screening Finds More Breast Cancers, but at What Cost? Even breast cancer survivors may find it tough to sort out benefits and harms Jul 24, 2019
<乌鸦传媒>No Cancer Risk Found With TNF Inhibitors in Psoriatic Arthritis Expected cancer cases similar to those in general populace, study shows Jun 13, 2019
<乌鸦传媒>Jury Out on Margetuximab in Advanced HER2+ Breast Cancer One-month PFS boost, but certain subgroups may derive more benefit Jun 05, 2019
<乌鸦传媒>Cancer Surgery Refusal Remains a Problem Older, unmarried, African-American patients more likely to say 'no' Jun 04, 2019
<乌鸦传媒>Dramatic OS Boost With Kisqali in Young Breast Ca Patients 'First study to demonstrate improved survival for a targeted therapy' in advanced disease Jun 02, 2019 video
<乌鸦传媒>Hormones Tied to Increased Breast Cancer Risk for Trans Women Overall risk still lower than cisgender women, however, and small overall May 14, 2019
<乌鸦传媒>Detailed Policy Cuts Opioid Use After Breast Ca Surgery 40% of women reported zero narcotic use after surgery May 03, 2019
<乌鸦传媒>Omitting Chemo Feasible in First-Line HER2+ Breast Cancer? De-escalation showed mixed results in metastatic disease May 01, 2019
<乌鸦传媒>CAR T-Cell Therapy Active in Solid Tumors Preliminary data on safety, efficacy in mesothelioma, sarcomas Mar 31, 2019 video
<乌鸦传媒>Are Patients Better Off With Image-Guided Bone Marrow Biopsy? Prospect of sedation has some going to interventional radiology Mar 29, 2019
<乌鸦传媒>Vaccine Prolongs Remission in Triple-Negative Breast Cancer Effect in hard-to-treat subgroup "clinically meaningful" Mar 07, 2019
<乌鸦传媒>Black History Month: Talking With Jennifer Webb, MD How mentorship helped her overcome barriers Feb 28, 2019
<乌鸦传媒>Patients Say Quality of Life Suffered With Mastectomy for Early Breast Cancer Breast-conservation options were associated with better sexual, psychosocial outcomes Dec 07, 2018
<乌鸦传媒>SABCS: Axillary RT as Good as Surgery in Breast Cancer Radiation non-inferior to surgery after positive sentinel node Dec 07, 2018
<乌鸦传媒>Low-Dose Tamoxifen Feasible Option in Breast Cancer Women appear to prevent recurrence in early stage cancers with 5 mg dosing Dec 06, 2018
<乌鸦传媒>Xeloda Disappoints in Early Triple-Negative Breast Cancer No improvement after standard chemo, though subset may derive some benefit Dec 05, 2018
<乌鸦传媒>T-DM1: A New Adjuvant Standard in High-Risk HER2+ Breast Ca? Substantial improvements in survival outcomes in KATHERINE trial Dec 05, 2018
<乌鸦传媒>SABCS: Translational Before It Was Cool Growing, evolving while adhering to founding principles Dec 03, 2018
<乌鸦传媒>Younger High-Risk Women Benefit From Mammography Yields in 30-39 age group at high risk comparable to 40-49 group with average risk Nov 30, 2018
<乌鸦传媒>Machine Learning Allows for Low-Dose Gadolinium Contrast Minimal loss of resolution with 10% Gd dose Nov 30, 2018
